Reference : L'insulinotherapie dans le diabete de type 2.
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
L'insulinotherapie dans le diabete de type 2.
[en] Insulin therapy in type 2 diabetes
Philips, Jean-Christophe mailto [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Revue Médicale de Liège
Le diabète sucré dans tous ses états
Yes (verified by ORBi)
[en] Blood Glucose ; Clinical Trials as Topic ; Diabetes Mellitus, Type 2/drug therapy ; Humans ; Hypoglycemia ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Risk Factors
[en] As compared to type 1 diabetes, type 2 diabetes usually requires insulin at a late stage, after secondary failure to oral antidiabetic drugs. However, it should be pointed out that insulin therapy should not be delayed in patients not well controlled on oral agents. Type 2 diabetic patients failing to oral antidiabetic medications need insulin. Nevertheless, insulin therapy in type 2 diabetic patients is less standardized than in those with type 1 diabetes. Several clinical trials tried to investigate what is the most appropriate initial insulin therapy in type 2 diabetic patients, with the main objectives of reaching almost normoglycaemia without increased risk of frequent or severe hypoglycaemic episodes. However, there is no agreement upon optimal mode of initiating insulin. The most important factors leading to adequate metabolic control are a global educational approach together with a intensified follow up, independently of the insulin regimen.
Researchers ; Professionals ; Students

File(s) associated to this reference

Fulltext file(s):

Open access
20050506_28.pdfNo commentaryPublisher postprint440.95 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.